Labeler
Amneal Pharmaceuticals LLC NDC Codes
Amneal Pharmaceuticals LLC lists 481 finished drug products in the FDA NDC Directory under NDC labeler codes 60219, 60846, 64896, 65162, 69238, 70121.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lisdexamfetamine Dimesylate, Valsartan and Hydrochlorothiazide, Lurasidone Hydrochloride, Risperidone, Crexont, Ropivacaine Hydrochloride, Pitavastatin, Pemrydi Rtu, Lyvispah, Tepadina, Methylene blue, Exenatide, calcium chloride, Ongentys, Methylprednisolone acetate
- Active ingredients
- Lisdexamfetamine dimesylate, Valsartan, Hydrochlorothiazide, Lurasidone hydrochloride, Carbidopa hydrate, Levodopa, Ropivacaine hydrochloride, Pitavastatin calcium, Pemetrexed disodium hemipentahydrate, Baclofen, Denosumab, Thiotepa
- NDC labeler codes
- 60219, 60846, 64896, 65162, 69238, 70121
- Strengths (from the 100 most recently listed products)
- Hydrochlorothiazide 12.5 mg/1; Methylene blue 5 mg/mL; Exenatide 250 ug/mL; Calcium chloride 100 mg/mL; Valsartan 160 mg/1; Hydrochlorothiazide 25 mg/1; Valsartan 320 mg/1; Medroxyprogesterone acetate 150 mg/mL; Dexmedetomidine hydrochloride 4 ug/mL; Ropivacaine hydrochloride 2 mg/mL; Ropivacaine hydrochloride 5 mg/mL; Magnesium sulfate heptahydrate 40 mg/mL; Fluorometholone 1 mg/mL; Glycopyrrolate .2 mg/mL; Lanreotide acetate 120 mg/.5mL; Romidepsin 5 mg/mL; Denosumab 70 mg/mL; Denosumab 60 mg/mL; Phytonadione 1 mg/.5mL; Epinephrine 1 mg/mL
- Dosage forms
- Injection, Injection, Solution, Tablet, Film coated, Capsule, Kit, Tablet, Extended release, Tablet, Coated, Capsule, Extended release, Injection, Suspension, Tablet, Injection, Powder, Lyophilized, For solution, Granule, Solution, Suspension/ drops, Injection, Solution, Concentrate, Injection, Emulsion, Tablet, Delayed release, Spray, For solution, Gel
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Epidural, Infiltration, Perineural, Intracavitary, Intravesical, Intra-articular, Intralesional, Intrasynovial, Soft tissue, Topical, Ophthalmic, Nasal
- Drug classes (FDA established)
- Central Nervous System Stimulant, Osmotic Laxative, Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Atypical Antipsychotic, Aromatic Amino Acid, Corticosteroid, Amide Local Anesthetic, beta-Adrenergic Blocker, HMG-CoA Reductase Inhibitor, Potassium Salt, Anticholinergic, Cholinergic Muscarinic Antagonist, Folate Analog Metabolic Inhibitor, gamma-Aminobutyric Acid-ergic Agonist, RANK Ligand Inhibitor, Alkylating Drug, Oxidation-Reduction Agent, GLP-1 Receptor Agonist, Blood Coagulation Factor, Phosphate Binder, Catechol-O-Methyltransferase Inhibitor, Progestin, Central alpha-2 Adrenergic Agonist, Cytochrome P450 17A1 Inhibitor, Methylxanthine, Calculi Dissolution Agent, Serotonin-1b and Serotonin-1d Receptor Agonist, Peroxisome Proliferator Receptor alpha Agonist, Somatostatin Analog, Histone Deacetylase Inhibitor, Vitamin K, Warfarin Reversal Agent, Catecholamine, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Calcitonin, Central Nervous System Depressant, Ergotamine Derivative, Aminosalicylate, Tetracycline-class Drug, Cholinesterase Inhibitor, Proteasome Inhibitor, Substance P/Neurokinin-1 Receptor Antagonist, Opioid Antagonist, Pyrophosphate Analog DNA Polymerase Inhibitor, Sulfone, Hematopoietic Stem Cell Mobilizer, Nucleoside Metabolic Inhibitor, Phenothiazine, Nonsteroidal Anti-inflammatory Drug
- HCPCS / J-code
- J0897 — Injection, denosumab, 1 mg, J0171 — Injection, adrenalin, epinephrine, 0.1 mg, J1040 — Injection, methylprednisolone acetate, 80 mg, J1050 — Injection, medroxyprogesterone acetate, 1 mg
- Package NDCs
- 167 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Oxybutynin Chloride | Oxybutynin chloride 5 mg/1 | Tablet, Extended releaseOral | 65162-371 | 65162-0371-0365162-0371-0965162-0371-10+1 more | — |
| Oxybutynin Chloride | Oxybutynin chloride 10 mg/1 | Tablet, Extended releaseOral | 65162-372 | 65162-0372-0365162-0372-0965162-0372-10+1 more | — |
| Oxybutynin Chloride | Oxybutynin chloride 15 mg/1 | Tablet, Extended releaseOral | 65162-373 | 65162-0373-0365162-0373-0965162-0373-10+2 more | — |
| Dutasteride | Dutasteride .5 mg/1 | CapsuleOral | 65162-750 | 65162-0750-0365162-0750-09 | — |
| Rabeprazole Sodiumrabeprazole | Rabeprazole sodium 20 mg/1 | Tablet, Delayed releaseOral | 65162-724 | 65162-0724-0365162-0724-0965162-0724-11+1 more | — |
| Fluocinolone Acetonide | Fluocinolone acetonide .11 mg/118.28mL | OilTopical | 65162-703 | 65162-0703-86 | — |
| Aripiprazole | Aripiprazole 1 mg/mL | SolutionOral | 65162-893 | 65162-0893-74 | — |
| Lidocaine | Lidocaine 50 mg/g | OintmentTopical | 65162-918 | 65162-0918-4165162-0918-45 | — |
| Niacin | Niacin 500 mg/1 | Tablet, Extended releaseOral | 65162-321 | 65162-0321-0365162-0321-0965162-0321-50 | — |
| Niacin | Niacin 1000 mg/1 | Tablet, Extended releaseOral | 65162-323 | 65162-0323-0365162-0323-0965162-0323-50 | — |
| Rivastigmine | Rivastigmine 13.3 mg/24h | PatchTransdermal | 65162-749 | 65162-0749-34 | — |
| Rivastigmine | Rivastigmine 4.6 mg/24h | PatchTransdermal | 65162-825 | 65162-0825-34 | — |
| Rivastigmine | Rivastigmine 9.5 mg/24h | PatchTransdermal | 65162-826 | 65162-0826-34 | — |
| Divalproex Sodium | Divalproex sodium 250 mg/1 | Tablet, Extended releaseOral | 65162-755 | 65162-0755-1065162-0755-50 | — |
| Divalproex Sodium | Divalproex sodium 500 mg/1 | Tablet, Extended releaseOral | 65162-757 | 65162-0757-1065162-0757-50 | — |
| Temozolomide | Temozolomide 5 mg/1 | CapsuleOral | 65162-801 | 65162-0801-1465162-0801-51 | — |
| Temozolomide | Temozolomide 20 mg/1 | CapsuleOral | 65162-802 | 65162-0802-1465162-0802-51 | — |
| Temozolomide | Temozolomide 100 mg/1 | CapsuleOral | 65162-803 | 65162-0803-1465162-0803-51 | — |
| Temozolomide | Temozolomide 140 mg/1 | CapsuleOral | 65162-804 | 65162-0804-1465162-0804-51 | — |
| Temozolomide | Temozolomide 180 mg/1 | CapsuleOral | 65162-805 | 65162-0805-1465162-0805-51 | — |
| Temozolomide | Temozolomide 250 mg/1 | CapsuleOral | 65162-806 | 65162-0806-51 | — |
| Rytarycarbidopa and levodopa | Levodopa 95 mg/1; Carbidopa hydrate 23.75 mg/1 | Capsule, Extended releaseOral | 64896-661 | 64896-0661-0164896-0661-0964896-0661-43+1 more | — |
| Rytarycarbidopa and levodopa | Levodopa 145 mg/1; Carbidopa hydrate 36.25 mg/1 | Capsule, Extended releaseOral | 64896-662 | 64896-0662-0164896-0662-0964896-0662-43+1 more | — |
| Rytarycarbidopa and levodopa | Levodopa 195 mg/1; Carbidopa hydrate 48.75 mg/1 | Capsule, Extended releaseOral | 64896-663 | 64896-0663-0164896-0663-0964896-0663-43+1 more | — |
| Rytarycarbidopa and levodopa | Levodopa 245 mg/1; Carbidopa hydrate 61.25 mg/1 | Capsule, Extended releaseOral | 64896-664 | 64896-0664-0164896-0664-43 | — |
| Entecavir | Entecavir .5 mg/1 | Tablet, Film coatedOral | 65162-446 | 65162-0446-03 | — |
| Entecavir | Entecavir 1 mg/1 | Tablet, Film coatedOral | 65162-449 | 65162-0449-03 | — |
| Tobramycin | Tobramycin 300 mg/5mL | SolutionRespiratory (Inhalation) | 65162-914 | 65162-0914-46 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 25 ug/1 | TabletOral | 60846-801 | 60846-0801-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 50 ug/1 | TabletOral | 60846-802 | 60846-0802-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 75 ug/1 | TabletOral | 60846-803 | 60846-0803-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 88 ug/1 | TabletOral | 60846-804 | 60846-0804-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 100 ug/1 | TabletOral | 60846-805 | 60846-0805-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 112 ug/1 | TabletOral | 60846-806 | 60846-0806-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 125 ug/1 | TabletOral | 60846-807 | 60846-0807-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 137 ug/1 | TabletOral | 60846-808 | 60846-0808-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 150 ug/1 | TabletOral | 60846-809 | 60846-0809-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 175 ug/1 | TabletOral | 60846-810 | 60846-0810-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 200 ug/1 | TabletOral | 60846-811 | 60846-0811-01 | — |
| Unithroidlevothyroxine sodium | Levothyroxine sodium 300 ug/1 | TabletOral | 60846-812 | 60846-0812-01 | — |
| Itraconazole | Itraconazole 10 mg/mL | SolutionOral | 65162-087 | 65162-0087-3465162-0087-74 | — |
| Nevirapine | Nevirapine 200 mg/1 | TabletOral | 65162-209 | 65162-0209-06 | — |
| Milnacipran HCl | Milnacipran hydrochloride 12.5 mg/1 | TabletOral | 65162-091 | 65162-0091-06 | — |
| Milnacipran HCl | Milnacipran hydrochloride 25 mg/1 | TabletOral | 65162-092 | 65162-0092-06 | — |
| Milnacipran HCl | Milnacipran hydrochloride 50 mg/1 | TabletOral | 65162-093 | 65162-0093-0665162-0093-50 | — |
| Milnacipran HCl | Milnacipran hydrochloride 100 mg/1 | TabletOral | 65162-094 | 65162-0094-0665162-0094-50 | — |
| Acyclovir | Acyclovir 50 mg/g | OintmentTopical | 65162-835 | 65162-0835-9465162-0835-96 | — |
| Pyridiumphenazopyridine | Phenazopyridine hydrochloride 100 mg/1 | Tablet, Film coatedOral | 60846-501 | 60846-0501-01 | — |
| Pyridiumphenazopyridine | Phenazopyridine hydrochloride 200 mg/1 | Tablet, Film coatedOral | 60846-502 | 60846-0502-01 | — |
| Voriconazole | Voriconazole 40 mg/mL | Powder, For suspensionOral | 65162-913 | 65162-0913-22 | — |
Amneal Pharmaceuticals LLC: common questions
- What is Amneal Pharmaceuticals LLC's NDC labeler code?
- 60219, 60846, 64896, 65162, 69238, 70121. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Amneal Pharmaceuticals LLC?
- Med-Code's HCPCS directory matches J0897, J0171, J1040, J1050 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.